0001021771-24-000050.txt : 20240215 0001021771-24-000050.hdr.sgml : 20240215 20240215161945 ACCESSION NUMBER: 0001021771-24-000050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240213 FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paccasassi Robert CENTRAL INDEX KEY: 0001751339 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37603 FILM NUMBER: 24644075 MAIL ADDRESS: STREET 1: C/O BIORESTORATIVE THERAPIES, INC. STREET 2: 40 MARCUS DRIVE, SUITE 1 CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioRestorative Therapies, Inc. CENTRAL INDEX KEY: 0001505497 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 301341024 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: (631) 760-8100 MAIL ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: Stem Cell Assurance, Inc. DATE OF NAME CHANGE: 20101110 4 1 form4.xml X0508 4 2024-02-13 0001505497 BioRestorative Therapies, Inc. BRTX 0001751339 Paccasassi Robert C/O BIORESTORATIVE THERAPIES, INC. 40 MARCUS DRIVE, SUITE ONE MELVILLE NY 11747 true VP, QA and Reg Compliance false Stock Option 5.08 2031-11-04 Common Stock 8277 8277 D Stock Option 2.91 2033-02-17 Common Stock 88968 88968 D Stock Option 1.45 2024-02-13 4 A 0 219298 0 A 2034-02-13 Common Stock 219298 219298 D The option is currently exercisable. The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested. The option vests and becomes exercisable to the extent of 109,649 shares on February 13, 2024 with the remaining 109,649 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested. /s/ Robert Paccasassi 2024-02-13